Compare OCC & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCC | DXR |
|---|---|---|
| Founded | 1983 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.1M | 66.3M |
| IPO Year | 1996 | N/A |
| Metric | OCC | DXR |
|---|---|---|
| Price | $8.05 | $12.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 41.0K | 4.4K |
| Earning Date | 12-22-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $72,694,849.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.63 |
| Revenue Growth | ★ 12.67 | N/A |
| 52 Week Low | $2.03 | $6.55 |
| 52 Week High | $11.50 | $14.15 |
| Indicator | OCC | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 52.92 | 48.48 |
| Support Level | $7.81 | $12.65 |
| Resistance Level | $8.69 | $13.02 |
| Average True Range (ATR) | 0.62 | 0.45 |
| MACD | 0.14 | -0.04 |
| Stochastic Oscillator | 76.16 | 32.94 |
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.